glp-1 news 2025 november nov GLP-1 Receptor Agonist Market Growth Analysis New oral GLP-1 drug delivers
Description
In the UK, Wegovy tablets are currently the first GLP-1 tablet licensed for weight management in eligible adults
Theres no guidance on changing GLP-1 dosage for weight loss maintenance, but your doctor may be willing to experiment with smaller or less frequent injections
These foundational approaches address root causes rather than masking appetite signals
GLP-1 and GLP-1 receptor agonists may represent novel drugs of therapeutic intervention with potential value, providing an alternative to the existing therapy for stroke
These changes may persist
